Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Breast 2Plasma cell 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 550Head and Neck Neoplasms 490Carcinoma, Non-Small-Cell Lung 338Melanoma 217Colorectal Neoplasms 206Ovarian Neoplasms 174Neoplasms 171Breast Neoplasms 168Stomach Neoplasms 141Carcinoma, Renal Cell 133Uterine Cervical Neoplasms 129Neoplasm Metastasis 129Triple Negative Breast Neoplasms 125Lung Neoplasms 118Pancreatic Neoplasms 117Esophageal Neoplasms 107Thyroid Neoplasms 95Endometrial Neoplasms 93Urinary Bladder Neoplasms 92Prostatic Neoplasms 88Sarcoma 81Carcinoma, Squamous Cell 81Carcinoma, Transitional Cell 75Small Cell Lung Carcinoma 74Carcinoma, Hepatocellular 65Recurrence 53Nasopharyngeal Carcinoma 52Carcinoma 47Colonic Neoplasms 46Cholangiocarcinoma 43

Interventions

Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Humoral Hypercalcemia Of Malignancy × Head & Neck × Clear all
NCT00896454 2018-10-17

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Amgen

Phase 2 Completed
33 enrolled 22 charts
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cellThoracic

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Hypercalcemia, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Parathyroid Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡